hypogonadism; testosterone; fda; mens health

The FDA encourages the public to comment in docket FDA-2025-N-6743 Expert Panel on Testosterone Replacement Therapy for Men. https://www.federalregister.gov/public-inspection/2025-22466/request-for-information-expert-panel-on-testosterone-replacement-therapy-for-men An unpublished Notice by...

In this episode, Dr. Morgentaler and Dr. Brandon talk about the FDA finally reversing its stance on testosterone risks, what that means for heart health, and why it’s a big win for science—and for patients. Chapters 00:07 – FDA's New Stance on Testosterone In this episode, Dr. Morgentaler...

https://www.medscape.com/viewarticle/physicians-welcome-testosterone-labeling-changes-2025a10006gq?form=fpf Marius Pharmaceuticals, which markets Kyzatrex (testosterone undecanoate) capsules, indicated further studies of testosterone could be coming. Shalin Shah, CEO of the company, said in a...